Last reviewed · How we verify

NCT05997004

Glycopyrrolate Prophylaxis for Prevention of Bradyarrhythmia During Laparoscopic Cholecystectomy

Completed NA Last updated 28 August 2023
What this trial tests

NA trial testing Normal Saline in Bradyarrhythmia in 62 participants. Completed in 15 November 2019.

Timeline
1 May 2018
Primary endpoint
20 May 2019
15 November 2019

Quick facts

Lead sponsorNational Academy of Medical Sciences, Nepal
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposeprevention
Enrollment62
Start date1 May 2018
Primary completion20 May 2019
Estimated completion15 November 2019
Sites1 location across Nepal

Drugs / interventions tested

Conditions studied

Sponsor

National Academy of Medical Sciences, Nepal — full company profile →

Who can join

Adults 15 to 65, any sex, with Bradyarrhythmia or Cardiac Arrest. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this clinical trial is to evaluate the incidence of bradycardia during laparoscopic cholecystectomy. The main question\[s\] it aims to answer are: * Does bradycardia really occurs during pneumoperitoneum/laparoscopic surgery? * If the patient get Glycopyrrolate, Does it really prevent pneumoperitoneum/laparoscopic surgery induced bradycardia?

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Normal Saline

Trials testing the same drug.

Other recruiting trials for Bradyarrhythmia

Currently open trials in the same condition.

Other National Academy of Medical Sciences, Nepal trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05997004.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing